Treatments using a patient’s own T cells to target cancer have applied advances in genetic engineering and cancer immunotherapy as the basis for a powerful, targeted cell-based therapy. Tumor-infiltrating lymphocytes and T cells that have been genetically modified to express cancer antigen-specific receptors—such as T cell receptors (TCRs) and chimeric antigen receptors (CARs)—leverage the innate targeted cytotoxicity of T cells against cancer. Despite promising results in clinical trials, these therapies have elicited serious and sometimes fatal responses. These toxicities include killing of healthy tissue expressing lower levels of antigen, as well as an overstimulation of the immune response called cytokine release syndrome. These outcom...
T-lymphocytes (T-cell) therapy offers a treatment for cancers. Developing this technology in the fut...
Adoptive transfer of engineered T cells has shown striking clinical success in treating refractory l...
Chimeric antigen receptor (CAR) T cells have shown great promise in the treatment of hematological a...
Adoptive T cell immunotherapy is a promising anti-cancer therapy that has the potential to become th...
Recent conceptual as well as technological advances in the areas of molecular immunology, gene trans...
Thesis (Ph.D.)--University of Washington, 2017-08Adoptive T-cell therapy, particularly chimeric anti...
T cells are blood cells which organize the immune system of the host. These cells are necessary for ...
Dr. Carl June and his colleagues at the University of Pennsylvania have succeeded in treating patien...
Cell-based therapeutics have become a powerful method to combat cancer. Unlike small-molecule drugs ...
T-lymphocytes (T-cell) therapy offers a treatment for cancers. Developing this technology in the fut...
Engineering the immune system against cancer ideally provides surgical precision against the antigen...
Chimeric antigen receptors (CAR) are synthetic receptors that combine the single chain variable frag...
Human body have T cells in the immune system which protect the body from infection by pathogens and ...
Chimeric Antigen Receptor (CAR) T-cell therapy is a promising strategy for the treatment of human ca...
Thesis (Ph.D.)--University of Washington, 2018Revolutionary new cancer therapies are harnessing the ...
T-lymphocytes (T-cell) therapy offers a treatment for cancers. Developing this technology in the fut...
Adoptive transfer of engineered T cells has shown striking clinical success in treating refractory l...
Chimeric antigen receptor (CAR) T cells have shown great promise in the treatment of hematological a...
Adoptive T cell immunotherapy is a promising anti-cancer therapy that has the potential to become th...
Recent conceptual as well as technological advances in the areas of molecular immunology, gene trans...
Thesis (Ph.D.)--University of Washington, 2017-08Adoptive T-cell therapy, particularly chimeric anti...
T cells are blood cells which organize the immune system of the host. These cells are necessary for ...
Dr. Carl June and his colleagues at the University of Pennsylvania have succeeded in treating patien...
Cell-based therapeutics have become a powerful method to combat cancer. Unlike small-molecule drugs ...
T-lymphocytes (T-cell) therapy offers a treatment for cancers. Developing this technology in the fut...
Engineering the immune system against cancer ideally provides surgical precision against the antigen...
Chimeric antigen receptors (CAR) are synthetic receptors that combine the single chain variable frag...
Human body have T cells in the immune system which protect the body from infection by pathogens and ...
Chimeric Antigen Receptor (CAR) T-cell therapy is a promising strategy for the treatment of human ca...
Thesis (Ph.D.)--University of Washington, 2018Revolutionary new cancer therapies are harnessing the ...
T-lymphocytes (T-cell) therapy offers a treatment for cancers. Developing this technology in the fut...
Adoptive transfer of engineered T cells has shown striking clinical success in treating refractory l...
Chimeric antigen receptor (CAR) T cells have shown great promise in the treatment of hematological a...